Home › Funds › Bellevue Group AG › TNGX

Bellevue Group AG position in TNGX

TANGO THERAPEUTICS INC · Health Care

Bellevue Group AG reported holding 694,182 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.7M, representing 0.46% of its reported portfolio and ranking #50 among its reported holdings. Bellevue Group AG has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)694.18K sh
Reported value held$21.70M
Portfolio Weight0.46%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's TNGX position evolved

Bellevue Group AG first disclosed a stake in TNGX in Q4 2025 at 3,927,670 shares (US$34.8M). The position peaked in Q1 2026 at 2,400,000 shares, worth US$50.2M. Across 3 filings, Bellevue Group AG increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 694,182 shares valued at US$21.7M — a reduction of -1,705,818 shares quarter over quarter.. Notable position changes include a 39% trim in Q1 2026 (shares rose 49% over the following quarter), a 71% trim in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.93M $34.80M New
Q1 2026 2.40M $50.21M Reduce
Q2 2026 694.18K $21.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 85 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has Bellevue Group AG held TNGX?

Bellevue Group AG has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Bellevue Group AG's current position in TNGX?

As of Q2 2026, Bellevue Group AG holds 694.18K shares of TNGX (TANGO THERAPEUTICS INC), valued at $21.70M, representing 0.46% of its reported portfolio and ranking #50.

Has Bellevue Group AG been buying or selling TNGX?

In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in TNGX. The position peaked in Q1 2026 at 2.40M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 85 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.